These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23183148)

  • 21. Effect of curcumin on diabetic peripheral neuropathic pain: possible involvement of opioid system.
    Banafshe HR; Hamidi GA; Noureddini M; Mirhashemi SM; Mokhtari R; Shoferpour M
    Eur J Pharmacol; 2014 Jan; 723():202-6. PubMed ID: 24315931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat.
    Marchand F; Alloui A; Pelissier T; Hernández A; Authier N; Alvarez P; Eschalier A; Ardid D
    Brain Res; 2003 Aug; 980(1):117-20. PubMed ID: 12865165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated Administration of Amitriptyline in Neuropathic Pain: Modulation of the Noradrenergic Descending Inhibitory System.
    Hiroki T; Suto T; Saito S; Obata H
    Anesth Analg; 2017 Oct; 125(4):1281-1288. PubMed ID: 28787345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible involvement of cholinergic and opioid receptor mechanisms in fluoxetine mediated antinociception response in streptozotocin-induced diabetic mice.
    Anjaneyulu M; Chopra K
    Eur J Pharmacol; 2006 May; 538(1-3):80-4. PubMed ID: 16650402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic benefits of serotonin and noradrenaline reuptake inhibition.
    Nelson JC
    Depress Anxiety; 1998; 7 Suppl 1():5-6. PubMed ID: 9597344
    [No Abstract]   [Full Text] [Related]  

  • 26. Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal.
    Aley KO; Levine JD
    J Neurosci; 1997 Jan; 17(2):735-44. PubMed ID: 8987795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
    Lee SI; Keltner NL
    Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
    [No Abstract]   [Full Text] [Related]  

  • 28. Glial cell line-derived neurotrophic factor-mediated enhancement of noradrenergic descending inhibition in the locus coeruleus exerts prolonged analgesia in neuropathic pain.
    Kimura M; Sakai A; Sakamoto A; Suzuki H
    Br J Pharmacol; 2015 May; 172(10):2469-78. PubMed ID: 25572945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible mechanism of protective effect of thalidomide in STZ-induced-neuropathic pain behavior in rats.
    Taliyan R; Sharma PL
    Inflammopharmacology; 2012 Apr; 20(2):89-97. PubMed ID: 22179948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test.
    Dhir A; Kulkarni SK
    Pharmacology; 2007; 80(4):239-43. PubMed ID: 17622775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ; Gobert A; Lejeune F; Newman-Tancredi A; Rivet JM; Auclair A; Peglion JL
    J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved.
    Zhao X; Xu Y; Zhao Q; Chen CR; Liu AM; Huang ZL
    Neuropharmacology; 2012 Feb; 62(2):843-54. PubMed ID: 21945716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats.
    Marchand F; Alloui A; Chapuy E; Jourdan D; Pelissier T; Ardid D; Hernandez A; Eschalier A
    Pain; 2003 Jun; 103(3):229-235. PubMed ID: 12791429
    [No Abstract]   [Full Text] [Related]  

  • 34. Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.
    Filip M; Wydra K; Inan SY; Dziedzicka-Wasylewska M; Przegaliński E
    Eur J Pharmacol; 2004 Sep; 498(1-3):143-51. PubMed ID: 15363988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat.
    Sawynok J; Esser MJ; Reid AR
    Pain; 1999 Aug; 82(2):149-158. PubMed ID: 10467920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term administration of fluvoxamine attenuates neuropathic pain and involvement of spinal serotonin receptors in diabetic model rats.
    Kato T; Kajiyama S; Hamada H; Kawamoto M
    Hiroshima J Med Sci; 2013 Dec; 62(4):83-9. PubMed ID: 24597211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venlafaxine in obsessive-compulsive disorder.
    Yaryura-Tobias JA; Neziroglu FA
    Arch Gen Psychiatry; 1996 Jul; 53(7):653-4. PubMed ID: 8660133
    [No Abstract]   [Full Text] [Related]  

  • 38. Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain.
    Yalcin I; Tessier LH; Petit-Demoulière N; Doridot S; Hein L; Freund-Mercier MJ; Barrot M
    Neurobiol Dis; 2009 Mar; 33(3):386-94. PubMed ID: 19084064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin and noradrenaline reuptake inhibitors in animal models of pain.
    Mochizucki D
    Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S15-9. PubMed ID: 15378668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihyperalgesic and antiallodynic effects of mianserin on diabetic neuropathic pain: a study on mechanism of action.
    Üçel Uİ; Can ÖD; Demir Özkay Ü; Öztürk Y
    Eur J Pharmacol; 2015 Jun; 756():92-106. PubMed ID: 25771454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.